FDA Data Suggests Biologic Therapies May Be Linked to Hair Loss

New research, published in the Archives of Dermatological Research, analyzed data from the FDA's Adverse Event Reporting System (FAERS) between 2018 and 2024. The findings indicate a disproportionately high rate of hair loss reports among patients using biologic medications. This discovery suggests a need for increased vigilance and patient counseling regarding hair loss as a potential adverse effect of these therapies.